The potential long-term comparative effectiveness of larotrectinib versus entrectinib for treatment of metastatic TRK fusion colorectal cancer.

Authors

null

Kangho Suh

University of Pittsburgh, Pittsburgh, PA

Kangho Suh , Josh John Carlson , Fang Xia , Todd E. Williamson , Sean D Sullivan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

DOI

10.1200/JCO.2022.40.4_suppl.040

Abstract #

40

Poster Bd #

B8

Abstract Disclosures

Similar Posters

First Author: Kangho Suh

Poster

2023 ASCO Annual Meeting

An application of extrapolating clinical data from single-arm trials to assess comparative effectiveness.

An application of extrapolating clinical data from single-arm trials to assess comparative effectiveness.

First Author: Kangho Suh

First Author: Alexander E. Drilon

First Author: David S. Hong